Proto Labs Other Operating Income or Expenses 2010-2024 | PRLB

Proto Labs other operating income or expenses from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Proto Labs Annual Other Operating Income or Expenses
(Millions of US $)
2023 $-0
2022 $-125
2021 $0
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $-1
2009 $
Proto Labs Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31 $-0
2023-09-30 $-0
2023-06-30 $-0
2023-03-31 $-0
2022-12-31 $-119
2022-09-30 $-1
2022-06-30 $-5
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
Sector Industry Market Cap Revenue
Industrial Products Rubber & Plastic Products $0.992B $0.504B
Proto Labs, Inc. is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. It produces CNC machined and injection molded plastic parts. Proto Labs targets their services to product developers who use three-dimensional computer-aided design to develop products across a diverse range of end-markets. The Company has locations in the United States, the United Kingdom, Germany, Japan, Italy, France, and Spain. Proto Labs, Inc. is headquartered in Maple Plain, Minnesota.
Stock Name Country Market Cap PE Ratio
Essentra (FLRAF) United Kingdom $0.602B 0.00
Myers Industries (MYE) United States $0.455B 10.72
Trinseo (TSE) United States $0.163B 0.00